Abstract Reimbursement for genetic counseling services was examined at a single institution. Patient encounters utilizing the 96040 CPT® code from 7/31/2009 through 7/31/2013 were reviewed. Exclusion criteria included billing records of patients seen by a physician the same day, self-pay, Medicaid, and Medicare patients. Of the 8,630 encounters with a genetic counselor, 582 encounters were eligible for review. Descriptive statistics (i.e., percentage of encounters receiving some level of reimbursement, average reimbursement rate, number of third party payors providing any level of reimbursement, and number of ICD-9 codes receiving any level of reimbursement) depicted reimbursement of the 96040 CPT® code for the encounters analyzed. Statistical analysis found a significant difference in reimbursement between third party payors that do and do not credential genetic counselors (p < .0001). There was no statistically significant difference between reimbursement rates for primary diagnostic ICD-9 codes when compared to primary diagnostic ICD-9 V codes used. Results will provide a useful baseline for local and national comparisons due to the paucity of data regarding CPT® 96040.
Introduction
As the field of genetic counseling continues to progress, billing and reimbursement of genetic counseling services remain unclear. The difficulties posed by complications with reimbursement have limited the ability to integrate and access the services of genetic counselors into the health care system (Harrison et al. 2010) . Lack of access to genetic counselors means:
…people more frequently will be asked to consider these [genetic] tests or will be given results by health providers who have had relatively little training in medical genetics. Many of these providers have not been exposed to the idea of nondirective counseling, and they frequently work under pressures that limit the time that can be spent in discussion (Walker 2009, pp. 18-19) .
Further understanding of levels of reimbursement for genetic counselors and factors influencing reimbursement is needed because: Problems with coverage and reimbursement limit access to comprehensive genetic services within the health care system and may lead to poor quality of care if genetic services are provided by practitioners who have better billing and reimbursement mechanisms but no specialized training in genetics (Latchaw et al. 2010, pp. 525) .
When genetic counselors were surveyed to assess the barriers, limitations, and advantages of different service delivery models, improving billing and reimbursement for these services is necessary toward maintaining any service model.^ (Cohen et al. 2013, pp. 420 ) Unfortunately, a recent study showed genetic counselors usually do not know the level of reimbursement their services are receiving (Cohen et al. 2016) and there is little research on reimbursement levels to date.
One reason may be that genetic counselors did not have a Current Procedural Terminology (CPT) code to bill for genetic counseling services until 2007. The American Medical Association (AMA) maintains the Current Procedural Terminology (CPT®), which is the medical nomenclature used to report medical procedures and services under public and private health insurance programs. The CPT codes provide a standardized format by which to communicate the services rendered to a patient. The AMA approved the CPT® code, Medical Genetics and Genetic Counseling Services (96040), in 2007 for services provided by a trained, nonphysician genetic counselor. (Beebe et al. 2006) The CPT® 96040 code is a time-based code. Each time the code is billed represents thirty minutes of face-to-face time with a genetic counselor. The CPT® 96040 code can be utilized for services provided by genetic counselors including:
…obtaining a structured family genetic history; constructing a multiple generation genetic pedigree; and performing an analysis of available medical information for genetic risk assessment, psychosocial assessment, and counseling of the patient and family. (Parman 2010, pp. 16 ) Gustafson et al. (2011) analyzed the implementation of the new CPT® 96040 code. Using records identified with the 96040 code, patient encounters in multiple institutions in Cleveland, Ohio between January 2008 to February 2009 were reviewed. Cases identified as self-pay or with Medicare/Medicaid were excluded. The patient records were tracked and analyzed for third party private payor reimbursement. Out of the 289 eligible patient records, more than half (62.6%) received partial or full reimbursement. Of the 37.4% not reimbursed, reasons included Bcoding concerns,^Bpolicy limitations,^Bbundling of services,^and Bregistration or preauthorization^problems. Harrison et al. (2010) also investigated the impact of having a new CPT® code for genetic counseling (96040) and issues with implementation of the code. A survey sent to all National Society of Genetic Counselors (NSGC) members in the NSGC listserv asked nineteen questions about the respondents' demographics, billing knowledge, and billing practices. A total of 387 people completed the survey, giving the study a 32% response rate for those who opened the email. Twenty-four respondents reported the rate of reimbursement with the new code, which ranged from as little as 10% to more than 71%. For those who did not implement the CPT® 96040 code, reasons included issues with genetic counselor credentialing, need for licensure, and institutional policies.
The International Classification of Disease (ICD) may also affect reimbursement of genetic counseling services. At the time of this study, the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) was used. ICD-9-CM was the official system of assigning codes to diagnoses, signs and symptoms of a condition, and other reasons for an encounter (now on the tenth revision). The ICD-9 codes are assigning codes for diagnoses associated with inpatient, outpatient, and physician office utilization in the U.S. (Centers for Disease Control and Prevention 2009). ICD-9 codes which begin with the letter BV^are often referred to as BV codes^. The ICD-9 V codes are:
…designed to be used when a person who is not currently sick receives health services for some specific purpose, such as Bto discuss a problem which is in itself not a disease or injury^or when Bsome circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury^(NSGC Billing and Reimbursement Toolkit 2013, pp. 3).
Many of the ICD-9 codes utilized by genetic counselors are ICD-9 V codes, such as family or personal history of a health condition. It has been recommended that, BIf more than one ICD-9-CM code is appropriate to use for a particular patient, it is acceptable to use both V codes and non-V codes together( NSGC Billing and Reimbursement Toolkit 2013, pp. 3). Gustafson et al. (2011) further evaluated the reimbursement of genetic counseling services by comparing the ICD-9 codes (n = 147) versus the ICD-9 V codes (n = 142), and found no statistical significance between the two codes (p = .39). This is surprising because information within the genetic counseling community states that, Bthese [V] codes are often not reimbursed, whenever possible, it is best to use an actual diagnostic code as opposed to a V code for the primary diagnosis( NSGC Billing and Reimbursement Toolkit 2013) . Cohen et al. (2013) noted the need for ongoing local and national initiatives to improve professional recognition and reimbursement for genetic counseling services. The article states, B[c]ontinued efforts to improve billing for the reimbursement for services provided by genetic counselors are critical to the sustainability of any service delivery model.T o continue to understand how to improve billing and reimbursement, baseline data regarding the billing and reimbursement of the CPT® 96040 code are needed. This study will provide baseline data for billing and reimbursement of genetic counseling services in a single institution over a four year period. This study will also evaluate the reimbursement of genetic counseling services based on the ICD-9 code utilized and on credentialing of genetic counselors through third party payors as these were also possible barriers to implementation brought up in Gustafson et al. (2011) and Harrison et al. (2010) .
Materials and Methods

Study Design
The reimbursement amount and ICD-9 codes for all CPT® 96040 codes billed for all genetic counseling encounters occurring in the Sanford Health system in the state of South Dakota from July 31, 2009 to July 31, 2013 were reviewed. The de-identified data were provided by Sanford Health Patient Financial Services. Information obtained included: insurance provider, service date, CPT® 96040 code, number of times the code was billed, amount paid by insurance provider, amount paid by patient, genetic counselor who provided services, clinic location, and ICD-9 codes billed. Billing records of self-pay patients, Medicaid patients, and Medicare patients were excluded, as was done in the Gustafson et al. 2011 study. At the time the encounters occurred, it was the institutional policy not to bill patients a separate genetic counseling fee if the patient was also seeing a physician in the same facility on the same day. Therefore, patients seen by a physician the same day of the genetic counseling appointment were also excluded.
Data Analysis
Descriptive statistics were conducted for all eligible encounters and included the average level of reimbursement, number of times the code was billed, ICD-9 codes billed, and third party payors billed. Third party payors billed were divided into those that credential genetic counselors, those that do not, and those for which Sanford Health was not contracted thus making credentialing unobtainable. The reimbursements from insurance claims were examined and categorized as a proportion of total charges billed by any level of reimbursement, full reimbursement, or greater than 50% reimbursement.
A generalized linear model using a binomial link function and a specific contrast was used to compare the third party payors that credential genetic counselors and those that do not. Statistical significance was determined using α = 0.05.
The reimbursement of the primary diagnostic ICD-9 code was examined by comparing the ICD-9 codes versus ICD-9 V codes with a Fisher's two-tailed exact test. Because it is possible to use more than one diagnostic code, a second Fisher's two-tailed exact test was performed to determine if the removal of the primary diagnostic ICD-9 V codes billed with ICD-9 codes affected the analysis of the reimbursement level.
Results
Assessment of Encounters
A total of 8628 encounters were billed using the CPT® 96040 code between July 31, 2009 to July 31, 2013 at Sanford Health in South Dakota. Of those, 7618 encounters were removed due to the patient being seen by a physician the same day of the genetic counseling appointment. Of the 1010 encounters receiving charges, 428 encounters were removed because the patients were either self-pay, Medicaid, or Medicare patients.
The remaining 582 encounters were eligible for review and the CPT® 96040 code was utilized 705 times. Of the encounters, 52.75% received partial or full reimbursement with the overall average reimbursement rate at 42.44%. Of all the CPT® 96040 codes billed, 54.04% received partial or full reimbursement with an average reimbursement rate of 34.49%.
The reimbursement rate based on the number of billed CPT® 96040 codes has not previously been reported in the peer-reviewed literature. Of the 120 encounters that were billed using the CPT® 96040 code two or more times with full reimbursement for the first CPT® 96040 code billed, 60.00% received some reimbursement for the remaining number of the CPT® 96040 codes billed. Full reimbursement was received for 25.00% of the remaining number of CPT® 96040 codes billed.
Assessment of Third Party Payors
A total of 31 third party payors were billed. Of these, 27 provided partial or full reimbursement.
Assessment of ICD-9 Codes
A total of 85 different ICD-9 codes were utilized of which 51 were ICD-9 codes and 34 were ICD-9 V codes. A total of 54 codes (60.67%) received partial or full reimbursement. Thirty of the codes were ICD-9 codes and 24 of the codes were ICD-9 V.
Analysis of ICD-9 Codes Versus ICD-9 V Codes
There was no statistical significance between the primary diagnostic ICD-9 codes and ICD-9 V codes for reimbursement rate as shown in Table 1 .
There was no statistical significance between the reimbursement rate of primary diagnostic ICD-9 codes and ICD-9 V codes even when the ICD-9 V codes billed with additional ICD-9 codes were removed (as shown in Table 2 ).
Analysis of Credentialing Status among Third Party Payors
Third party payors were divided into those that credential genetic counselors (n = 10), those that do not (n = 9), and those for which Sanford Health is not contracted making credentialing unattainable (n = 12).
The reimbursement for services from the 31 third party payors was examined as a proportion of total amount billed per credentialing category, as shown in Fig. 1 .
A generalized linear model using a binomial link function and a specific contrast was used to compare the third party payors that credential genetic counselors (n = 10) and third party payors that do not (n = 9) based on proportions as shown in Table 3 . This was performed using an F-test.
Discussion
This study analyzed the reimbursement rate and characteristics of genetic counseling services. The purpose was to analyze billing and reimbursement of genetic counseling services to collect data that will contribute to future research.
Of the 582 encounters billed using the CPT® 96040 included in the analysis, our findings of the level of reimbursement and average reimbursement rate were similar to what has been reported in the literature. Our number of encounters receiving partial or full reimbursement of 52.75% is comparable to the Gustafson et al. 2011 where 62.6% of encounters received partial or full reimbursement and our average reimbursement level of 42.44% fell into the 10% to 71% range found in the Harrison et al. 2010 study.
When comparing encounters with two or more CPT® 96040 codes billed to encounters billed once, 25.00% of encounters billed two or more times received full reimbursement compared to 30.74% for encounters billed with the CPT® 96040 code once. These findings may indicate that reimbursement is not dependent on number of time the CPT® 96040 is billed, which may be intrinsically valuable to the profession as genetic counseling can be a lengthy process, depending on each patient's circumstances.
Of the 85 different ICD-9 codes utilized, V16.3 representing a family history of malignant neoplasm of breast was utilized more than one fourth of the time (27.38%) and 174.9 representing malignant neoplasm of breast (female) unspecified site was the second most utilized code at 18.01%. Having a personal or family history of breast cancer represented 45.39% of the times the CPT® 96040 code was billed. This showed the majority of codes were associated with breast cancer with the remaining being associated with anything other than pediatrics.
A majority of the primary diagnostic ICD-9 V codes billed for each encounter were the sole ICD-9 code billed (n = 120) or billed in conjunction with another ICD-9 V code (n = 229). A small percentage (6.18%) of ICD-9 V codes were billed in conjunction with ICD-9 codes (n = 23). For the primary diagnostic ICD-9 V codes which were the sole ICD-9 code billed, 50.00% received partial or full reimbursement with an average reimbursement rate of 41.46%. For the primary diagnostic ICD-9 V codes which were billed in conjunction with another ICD-9 V code, 48.47% received partial or full reimbursement with an average reimbursement rate of 40.65%. For the primary diagnostic ICD-9 V codes billed in conjunction with another ICD-9 code and not an ICD-9 V code, 52.17% received partial or full reimbursement with an average reimbursement rate of 42.61%. The intention for further analysis of the ICD-9 V codes that were not billed in conjunction with an ICD-9 code was to remove the confounding variable of an ICD-9 code potentially affecting the reimbursement of ICD-9 V codes.
Additionally, the effect of using ICD-9 codes versus the ICD-9 V codes on reimbursement was examined. There was no statistically significant difference between the ICD-9 codes and the ICD-9 V codes (p = .3585). Importantly, these results support not only our hypothesis but also the findings of Gustafson et al. (2011) .
An analysis was also performed removing the primary diagnostic ICD-9 V codes billed with additional ICD-9 codes. There was also no statistically significant difference between the ICD-9 codes and the ICD-9 V codes (p = .2191). The NSGC Billing and Reimbursement Toolkit (2013) states, B[s]ince these codes are often not reimbursed, whenever possible, it is best to use an actual diagnostic code as opposed to a BNone^represents number of ICD-9 codes that did not receive any level of reimbursement, and BSome^represents number of ICD-9 codes that did receive any level of reimbursement BNone^represents number of ICD-9 codes that did not receive any level of reimbursement, and BSome^represents number of ICD-9 codes that did receive any level of reimbursement V code for the primary diagnosis.^Based on the information provided by this and previous studies, this statement may need to be reevaluated. Third party payors that credential genetic counselors were compared with those that do not. This resulted in a significant difference between the two groups regardless of the amount of reimbursement (p < .0001). This supports the hypothesis that credentialing through third party payors has a positive effect on the reimbursement of genetic counseling services. For those third party payors that could not credential the genetic counselors due to lack of contracting with the facility, the reimbursement proportions were higher compared to third party payors not credentialing genetic counselors.
Conclusions
Characterizing the reimbursement rates of genetic counseling services is important because it may provide a counterpoint to the perception, B[i]t's a disincentive for oncologists [and other healthcare practitioners] to have a genetic counselor in their practice because it's hard for counselors to generate their own salary^ (Garber et al. 2008) . This study provides evidence that genetic counseling services are being reimbursed, and argues the need for changes to billing practices and institutional policies to reflect the fact that genetic counselors can bill for their services.
The data provided in this study also argue the need for genetic counselors to continue to work on credentialing because credentialing had a significant positive impact on reimbursement rates. Because most third party payors will not credential a provider that is not licensed by the state, our analysis can be viewed as arguing for the need of licensure for genetic counselors in every state. According to Gettig and Greendale (2009), "[l] icensure may also have a positive Fig. 1 Proportion of total amount reimbursed. Note. Third party payors were divided into those that credential genetic counselors (Cred), those that do not (Not Cred), and those for which Sanford Health is not contracted making credentialing unattainable (Unable to Cred). The first category, BAverage Reimbursement,^is a simple summary of the average reimbursement proportions. The remaining categories are: any level of reimbursement, (BAny Reimbursement^) more than 50% of bill receiving reimbursement (BMajority Reimbursement^), or 100% reimbursement (BFull Reimbursement^) of the bill. CI = confidence interval 
Limitations
One limitation is that among the 31 third party payors billed, 17 had fewer than 10 encounters billed resulting in a small sample size that may skew some of the data. Second, the analysis of ICD-9 codes examined only the primary ICD-9 code selected, which does not take into account how additional ICD-9 codes may have affected reimbursement of the encounter. Of the 89 different ICD-9 codes used, 79 were used for fewer than 10 encounters billed. Low population numbers within each group makes the assessment of reimbursement rates for each ICD-9 code difficult to gauge.
The ICD-9 codes for having a personal or family history of breast cancer represented 45.39% of the times the CPT® 96040 code was billed, which may also skew the data as policies for coverage of genetic counseling can differ depending on the reason for referral. The fact that the ICD-9 codes utilized almost half of the time were associated with a personal or family history of breast cancer is at least partially due to patients seen for prenatal and reproductive/infertility at Sanford Health were also seen by physicians on the same day of the visits (making thoses cases excluded from this study).
While the primary ICD-9 code may be used to infer the service area of genetic counseling provided at Sanford Health (which were prenatal, reproductive/infertility, adult, and cancer), encounters were not sorted by counselor or service area. This is because each genetic counselor at Sanford Health provided genetic counseling services in all areas. Therefore, one cannot draw definitive correlations from the ICD-9 code and make an accurate assessment of genetic counseling services provided based on specialty.
Finally, our study did not provide any information on reimbursement of genetic counseling services for Medicaid, Medicare, self-pay patients, and services provided to patients seen by a physician the same day. Medicare does not recognize genetic counselors as medical providers and many Medicaid contractors were not and still do not cover genetic counseling, which is why these data were not analyzed. Not billing for services provided to patients on the same day as a provider was the institutional policy, which significantly reduced the number of cases to be analyzed.
Future Research
This study characterized the utilization of the CPT® 96040 code and the reimbursement rates in one state at one institution. As genetic services become more incorporated into other areas of health care, it will be important to understand and address factors that limit the ability to financially support genetic counseling services. While this study provided important baseline data and comparison of third party payors credentialing genetic counselors to third party payors that do not, future research is needed to characterize genetic counseling reimbursement. Repeating the analysis at the same institution within the next few years would be beneficial as well as replicating this study at other institutions.
Because the data analyzed in this study were after the state of South Dakota had licensure, it is not possible to determine if licensure significantly impacted reimbursement rates or credentialing of genetic counselors by third party payors. Research comparing reimbursement rates in a state before and after licensure goes into effect would be most helpful to determine if licensure has an effect on reimbursement.
The transition of the ICD-9 coding system to the ICD-10 coding system warrants further investigation of the impact of ICD-10 to determine whether this has had an impact on reimbursement rates as well. ICD-10 utilization began in October 2015.
Additionally, when considering the utilization of the CPT® 96040 code, BOne argument against this particular model is that the reimbursement levels for 96040 are lower than those received for the E&M codes^ (Gustafson et al. 2011) . It is important for the genetic counseling community to determine if this information is true, and should be considered for future research.
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